Company · CIK 1601830

# RECURSION PHARMACEUTICALS, INC.

| CIK | [1601830](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001601830) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | UT |
| Listed | RXRX (Nasdaq) |
| First annual or quarterly report | 2021-05-12 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-284878 | Shelf Effective | 2025-02-12 | 2026-10-15 | 5 |
| 333-264845 | Shelf Effective | 2022-05-10 | 2024-06-27 | 5 |
| 333-272281 | Shelf Effective | 2023-05-30 | 2023-05-30 | 1 |
| 333-254576 | IPO Final prospectus | 2021-03-22 | 2021-04-16 | 5 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-10-15 | [424B5](https://www.sec.gov/Archives/edgar/data/1601830/000160183026000134/0001601830-26-000134-index.htm) Shelf takedown | 333-284878 | 0001601830-26-000134 |
| 2026-10-15 | [424B5](https://www.sec.gov/Archives/edgar/data/1601830/000160183026000126/0001601830-26-000126-index.htm) Shelf takedown | 333-284878 | 0001601830-26-000126 |
| 2026-02-25 | [424B5](https://www.sec.gov/Archives/edgar/data/1601830/000160183026000041/0001601830-26-000041-index.htm) Shelf takedown | 333-284878 | 0001601830-26-000041 |
| 2025-02-28 | [424B5](https://www.sec.gov/Archives/edgar/data/1601830/000119312525040678/0001193125-25-040678-index.htm) Shelf takedown | 333-284878 | 0001193125-25-040678 |
| 2025-02-12 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1601830/000119312525025185/0001193125-25-025185-index.htm) Shelf registered | 333-284878 | 0001193125-25-025185 |
| 2024-06-27 | [424B5](https://www.sec.gov/Archives/edgar/data/1601830/000160183024000093/0001601830-24-000093-index.htm) Shelf takedown | 333-264845 | 0001601830-24-000093 |
| 2024-06-26 | [424B5](https://www.sec.gov/Archives/edgar/data/1601830/000160183024000088/0001601830-24-000088-index.htm) Shelf takedown | 333-264845 | 0001601830-24-000088 |
| 2023-08-08 | [424B5](https://www.sec.gov/Archives/edgar/data/1601830/000160183023000059/0001601830-23-000059-index.htm) Shelf takedown | 333-264845 | 0001601830-23-000059 |
| 2023-06-09 | [424B5](https://www.sec.gov/Archives/edgar/data/1601830/000160183023000042/0001601830-23-000042-index.htm) Shelf takedown | 333-264845 | 0001601830-23-000042 |
| 2023-05-30 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1601830/000160183023000036/0001601830-23-000036-index.htm) Shelf registered | 333-272281 | 0001601830-23-000036 |
| 2022-05-10 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1601830/000119312522146421/0001193125-22-146421-index.htm) Shelf registered | 333-264845 | 0001193125-22-146421 |
| 2021-04-16 | [424B4](https://www.sec.gov/Archives/edgar/data/1601830/000119312521119404/0001193125-21-119404-index.htm) Final prospectus | 333-254576 | 0001193125-21-119404 |
| 2021-04-15 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1601830/999999999521001450/9999999995-21-001450-index.htm) Declared effective | 333-254576 | 9999999995-21-001450 |
| 2021-04-15 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1601830/000119312521117033/0001193125-21-117033-index.htm) Amendment | 333-254576 | 0001193125-21-117033 |
| 2021-04-12 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1601830/000119312521112364/0001193125-21-112364-index.htm) Amendment | 333-254576 | 0001193125-21-112364 |
| 2021-03-22 | [S-1](https://www.sec.gov/Archives/edgar/data/1601830/000119312521089610/0001193125-21-089610-index.htm) Registration filed | 333-254576 | 0001193125-21-089610 |
| 2021-01-26 | [DRS](https://www.sec.gov/Archives/edgar/data/1601830/000095012321000614/0000950123-21-000614-index.htm) Draft made public | 377-04101 | 0000950123-21-000614 |

[All filings of this company](https://equitycapital.markets/filings?cik=1601830) · [CSV](https://equitycapital.markets/filings.csv?cik=1601830)

---
Source page: https://equitycapital.markets/company/1601830 · Data: U.S. SEC EDGAR · CC BY 4.0